SCHEMBL22343328

SCHEMBL22343328

CNc1cc(Nc2cccc3c2OCCO3)nc2c(C(=O)NC3CCC3)cnn12

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.68
▸ STAT3 P40763 1/20 0.66
▸ PDE4D Q08499 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22324702 0.97 TYK2 (0.71) TYK2STAT3PDE4D
SCHEMBL22342897 0.92 TYK2 (0.66) TYK2STAT3PDE4D
SCHEMBL22343297 0.92 TYK2 (0.61) TYK2STAT3
SCHEMBL22342924 0.91 TYK2 (0.79) TYK2STAT3PDE4D
SCHEMBL29746781 0.91 TYK2 (0.79) TYK2STAT3PDE4D
SCHEMBL22343339 0.90 TYK2 (0.59) TYK2STAT3PDE4D
SCHEMBL23327625 0.88 TYK2 (0.54) TYK2STAT3PDE4D
SCHEMBL22343338 0.88 TYK2 (0.69) TYK2PDE4D
SCHEMBL29746733 0.88 TYK2 (0.69) TYK2PDE4D
SCHEMBL22343330 0.88 TYK2 (0.72) TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348478-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2023-11-02 — — US disclosed
US-20230348478-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2023-11-02 — — US disclosed
US-11753411-B2 Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands VENTYX BIOSCIENCES, INC. (US) 2023-09-12 — — US disclosed
US-11753411-B2 Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands VENTYX BIOSCIENCES, INC. (US) 2023-09-12 — — US disclosed
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2022-05-05 — — US disclosed
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2022-05-05 — — US disclosed
US-20210139486-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2021-05-13 — — US disclosed
WO-2020163778-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. (US) 2020-08-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS TYK2, JAK2, PTK2B TYK2 1/4885STAT3 76/4885PDE4D 4544/4885
US-11753411-B2 Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands TYK2, JAK1, JAK2 TYK2 1/4885STAT3 376/4885PDE4D 3275/4885
US-20230348478-A1 TYK2 PSEUDOKINASE LIGANDS TYK2, JAK2, PTK2B TYK2 1/4885STAT3 76/4885PDE4D 4544/4885
US-20210139486-A1 TYK2 PSEUDOKINASE LIGANDS TYK2, JAK2, PTK2B TYK2 1/4885STAT3 76/4885PDE4D 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback